https://www.selleckchem.com/pr....oducts/zidesamtinib.
135). The main contraindication for transplantation was the cognitive disorders (66%) followed by the blood cancers (8%). This new specific activity, providing new source of fresh corneas for research immediately usable without any eyebank storage steps, didn't reduce the number of corneas procured for transplantation versus previous years (P = 0.998). Donors in the research group were 10 years older (P less then 0.001) without difference regarding endothelial cell quality (P = 0.071), allowing maximal clinical relevance for protoc
Like
Comment
Share
